ALS

Ionis Partners with Recordati to Expand Zilganersen Globally

CARLSBAD, Calif., June 25, 2026 Ionis Pharmaceuticals has entered into a landmark global licensing agreement with Recordati to accelerate...

By cGxPwire Editor
June 29, 2026

Veterinary

Anivive Wins FDA Approval for First Oral Canine Lymphoma Drug

LONG BEACH, Calif., June 26, 2026 Anivive Lifesciences has achieved a landmark milestone after the U.S. Food and Drug...

By cGxPwire Editor
June 29, 2026

.Clinical

NeuroSense PrimeC Shows Positive Phase 2 Alzheimer’s Biomarker Data

CAMBRIDGE, Mass., June 25, 2026 NeuroSense Therapeutics Ltd. announced positive biomarker findings from its Phase 2 randomized, double-blind, placebo-controlled...

By cGxPwire Editor
June 27, 2026

M&A

Lilly Completes Centessa Deal to Accelerate Treatments for Narcolepsy and Sleep-Wake Disorders

INDIANAPOLIS, June 24, 2026 Eli Lilly and Company announced the successful completion of its acquisition of Centessa Pharmaceuticals plc,...

By cGxPwire Editor
June 26, 2026

Bio-Pharma

AL-S Pharma Reports Positive Phase 2 AP-101 Data at ENCALS 2026

ZURICH, Switzerland, June 24, 2026 AL-S Pharma AG announced positive Phase 2 clinical results for its lead investigational antibody...

By cGxPwire Editor
June 26, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

.Clinical

Leal Therapeutics Doses First ALS Patient with LTX-002

WORCESTER, Mass. | June 23, 2026 Leal Therapeutics has announced that the first patient has been dosed in the...

By cGxPwire Editor
June 24, 2026

.VC

CervoMed Secures $10 Million to Advance Brain Disease Pipeline

BOSTON, June 18, 2026 CervoMed Inc., a clinical-stage biotechnology company focused on developing therapies for age-related neurological disorders, has...